載入...
Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients
INTRODUCTION: Anagliptin (ANA) improves dyslipidemia in addition to blood glucose levels. However, there are no comparative studies on the effects of ANA and other dipeptidyl peptidase‐4 inhibitors on serum lipid profile. We compared the effects of ANA on serum lipid profile with those of alogliptin...
Na minha lista:
| 發表在: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5835469/ https://ncbi.nlm.nih.gov/pubmed/28853228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12739 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|